ciprofloxacin has been researched along with chloroquine in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.72) | 18.7374 |
1990's | 3 (5.17) | 18.2507 |
2000's | 23 (39.66) | 29.6817 |
2010's | 27 (46.55) | 24.3611 |
2020's | 4 (6.90) | 2.80 |
Authors | Studies |
---|---|
Dunbar, DC; Ferreira, D; Jacob, MR; Li, XC; Muhammad, I; Tekwani, BL | 1 |
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S | 1 |
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
Bharate, SB; Chauthe, SK; Jacob, MR; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL; Yunus, NA | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Patel, SR; Patil, P; Tekwani, BL | 1 |
Ablordeppey, SY; Fan, P; Jacob, M; Khan, A; Khan, S; Li, S; Mardenborough, LG; Walker, L; Zhang, W; Zhu, XY | 1 |
Dahl, EL; Rosenthal, PJ | 1 |
Bharate, SB; Jacob, M; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Doerksen, RJ; Hamann, MT; Ibrahim, MA; Jacob, M; Khan, SI; Prasanna, S; Shilabin, AG | 1 |
Hamann, MT; Kasanah, N; Shilabin, AG; Tekwani, BL | 1 |
Ashfaq, MK; Jacob, MR; Joshi, VC; Khan, SI; Manly, SP; Muhammad, I; Samoylenko, V; Tekwani, BL; Walker, LA | 1 |
Ahmed, SA; Elsohly, MA; Khan, IA; Radwan, MM; Ross, SA; Slade, D | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Hamann, MT; Kudrimoti, S; Peng, J; Tekwani, BL; Wahba, AE | 1 |
Ahmed, SA; Elsohly, MA; Galal, AM; Gul, W; Jacob, MR; Khan, SI; Radwan, MM; Ross, SA; Slade, D; Tekwani, BL | 1 |
Anquetin, G; Biot, C; Dive, D; Dubar, F; Khalife, J; Pradines, B | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ferreira, D; Fronczek, FR; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Sen, S; Sinha, N | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Singh, PP; Singh, S; Tekwani, BL | 1 |
Duke, SO; Ferreira, D; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP; Tekwani, BL | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cutler, HG; Cutler, SJ; Dugan, FM; Gao, J; Hill, RA; Jacob, MR; Khan, SI; León, F; Lupien, S; Radwan, MM; Tekwani, BL; Wang, X | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Kalaria, PN; Raval, DK; Satasia, SP | 1 |
Karad, SC; Purohit, VB; Raval, DK | 1 |
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Amesty, Á; Anaissi-Afonso, L; Estévez-Braun, A; Hueso-Falcón, I; Lorenzo-Castrillejo, I; Machín, F | 1 |
Sankar, C; Umamatheswari, S | 1 |
Kashaw, SK; Kashaw, V; Mishra, M; Mishra, VK | 1 |
Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P | 1 |
Carvalho, P; Cutler, SJ; Dale, OR; Elokely, KM; ElSohly, MA; Galal Osman, A; Gul, W; Husni, AS; Khan, S; Klein, ML; Radwan, M; Ross, SA; Slade, D; Yadav, VK | 1 |
Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Zhao, CY | 1 |
Dana, S; Dhar, SK; Gurung, SK; Kumar, S; Mondal, N; Mukhopadhyay, P; Valissery, P | 1 |
Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Dolensky, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Petritsch, M; Saf, R; Schühly, W; Seebacher, W; Weis, R | 1 |
Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
Rollof, J; Vinge, E | 1 |
Biswas, S; Sharma, AK; Tripathi, KD; Valecha, N | 1 |
Singh, PS | 1 |
Hoelscher, M; Löscher, T | 1 |
Ono, C; Tanaka, M | 1 |
Adegbolagun, OM; Anumudu, CI; Kazzim, OJ; Osho, O | 1 |
Falkenberg, M; Scotti da Silva-Colombeli, A | 1 |
Agbasi, PU; Brown, SA; Elo-Ilo, J; Ilo, EC; Ilondu, NA; Okwoli, N; Orisakwe, OE | 1 |
Abiodun, OO; Gbotosho, GO; Happi, CT; Oduola, AM; Sowunmi, A; Woranola, O | 1 |
Abiodun, OO; Akinola, O; Falajiki, YF; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
Beberok, A; Boryczka, S; Marciniec, K; Pęcak, P; Wrześniok, D | 1 |
2 review(s) available for ciprofloxacin and chloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Quinoline and quinolone dimers and their biological activities: An overview.
Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Bacteria; Dimerization; Humans; Neoplasms; Quinolines; Quinolones | 2019 |
56 other study(ies) available for ciprofloxacin and chloroquine
Article | Year |
---|---|
Antimicrobial and antiparasitic (+)-trans-hexahydrodibenzopyrans and analogues from Machaerium multiflorum.
Topics: Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Benzopyrans; Candida albicans; Fabaceae; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plant Bark; Plants, Medicinal; Plasmodium falciparum; Staphylococcus aureus; Stereoisomerism | 2003 |
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera | 2004 |
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Cryptococcus neoformans; Epithelial Cells; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Phloroglucinol; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.
Topics: Aminoquinolines; Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiparasitic Agents; Bacteria; Chlorocebus aethiops; Erythrocytes; Fungi; Humans; Indicators and Reagents; L-Lactate Dehydrogenase; Leishmania donovani; Magnetic Resonance Spectroscopy; Methemoglobin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Bacteria; Cell Line; Cell Survival; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Fungi; Humans; Indicators and Reagents; Indole Alkaloids; Indoles; Isomerism; Leishmania donovani; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Vero Cells | 2007 |
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 2007 |
S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Biomimetic Materials; Leishmania donovani; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium avium Complex; Phloroglucinol; Plasmodium falciparum; Staphylococcus aureus; Structure-Activity Relationship; Terpenes | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
2-N-Methyl modifications and SAR studies of manzamine A.
Topics: Animals; Antimalarials; Carbazoles; Carbolines; Chlorocebus aethiops; Erythrocytes; Fibroblasts; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Kidney; Methylation; Models, Molecular; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2008 |
Kinetic studies and bioactivity of potential manzamine prodrugs.
Topics: Administration, Oral; Animals; Antimalarials; Candida albicans; Carbolines; Chlorocebus aethiops; Cryptococcus neoformans; Disease Models, Animal; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Prodrugs; Vero Cells | 2008 |
Indolizidine, antiinfective and antiparasitic compounds from Prosopis glandulosa var. glandulosa.
Topics: Animals; Anti-Infective Agents; Antiparasitic Agents; Aspergillus fumigatus; Brain; Candida albicans; Chloroquine; Cryptococcus neoformans; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Indolizidines; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Nevada; Plants, Medicinal; Plasmodium berghei; Prosopis | 2009 |
Biologically active cannabinoids from high-potency Cannabis sativa.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Aspergillus fumigatus; Candida; Cannabinoids; Cannabis; Chlorocebus aethiops; Escherichia coli; Gas Chromatography-Mass Spectrometry; Leishmania donovani; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Plasmodium falciparum; Pseudomonas aeruginosa | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Structure-activity relationship studies of manzamine A: amidation of positions 6 and 8 of the beta-carboline moiety.
Topics: Administration, Oral; Amides; Animals; Antimalarials; Carbazoles; Carbolines; Male; Mice; Mycobacterium avium Complex; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2009 |
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
Topics: Acetals; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Cryptococcus neoformans; Dimerization; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization | 2009 |
Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach.
Topics: Aminoquinolines; Antimalarials; Ciprofloxacin; Ferrous Compounds; Metallocenes; Plasmodium falciparum; Prodrugs | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Bioactive 1,4-dihydroxy-5-phenyl-2-pyridinone alkaloids from Septoria pistaciarum.
Topics: Alkaloids; Animals; Antimalarials; Ascomycota; Chlorocebus aethiops; Chloroquine; Crystallography, X-Ray; Methicillin-Resistant Staphylococcus aureus; Molecular Conformation; Molecular Structure; Plasmodium falciparum; Pyridones | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: synthesis and evaluation of anti-infective, β-haematin inhibition and cytotoxic activities.
Topics: Amino Acids; Aminoquinolines; Animals; Anti-Infective Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Dipeptides; Fungi; Hemeproteins; Leishmania donovani; Mice; Peptidomimetics; Plasmodium falciparum; Vero Cells | 2012 |
Antiprotozoal and antimicrobial compounds from the plant pathogen Septoria pistaciarum.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Ascomycota; Aspergillus fumigatus; Candida albicans; Candida glabrata; Chlorocebus aethiops; Chloroquine; Cryptococcus neoformans; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Plasmodium falciparum; Pseudomonas aeruginosa; Staphylococcus aureus; Vero Cells | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens.
Topics: | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors.
Topics: Coumarins; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Humans; Molecular Structure; Naphthoquinones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2017 |
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines | 2017 |
Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents.
Topics: Anti-Infective Agents; Antimalarials; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Pyrazoles; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared | 2017 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2017 |
Bioactive products from singlet oxygen photooxygenation of cannabinoids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen | 2018 |
Synthesis of Novel Ciprofloxacin-Based Hybrid Molecules toward Potent Antimalarial Activity.
Topics: | 2020 |
Preparation of new 1,3-dibenzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Candida albicans; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epidermis; Escherichia coli; Female; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pseudomonas aeruginosa; Quaternary Ammonium Compounds; Rats; Salts; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDS, and chloroquine: possible drug interaction.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Ciprofloxacin; Dizziness; Drug Interactions; Drug Therapy, Combination; Female; Humans; Peripheral Nervous System Diseases; Syncope | 1993 |
In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Topics: Animals; Chloroquine; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Plasmodium falciparum | 1993 |
Coexistence of enteric fever with malaria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Brain Diseases; Chloroquine; Ciprofloxacin; Drug Resistance; Humans; Malaria, Falciparum; Quinine; Tetracycline; Typhoid Fever | 1995 |
Advice for travelers.
Topics: Africa; Altitude Sickness; Asia; Chloroquine; Ciprofloxacin; Contraindications; Diarrhea; Female; Hepatitis A; Humans; Immunization; Loperamide; Malaria; Pregnancy; Travel; Viral Vaccines | 2002 |
[Malaria--case report].
Topics: Adult; Anti-Infective Agents; Antidiarrheals; Antimalarials; Chloroquine; Ciprofloxacin; Diarrhea; Emergencies; Fluid Therapy; Glasgow Coma Scale; Humans; Loperamide; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Nigeria; Parasitemia; Positive-Pressure Respiration; Proguanil; Quinine; Respiratory Distress Syndrome; Travel | 2003 |
Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
Topics: Binding Sites; Chloroquine; Ciprofloxacin; Drug Interactions; Enoxacin; Fluoroquinolones; Levodopa; Levofloxacin; Melanins; Monophenol Monooxygenase; Norfloxacin; Ofloxacin; Quinolones; Timolol | 2003 |
Additive effects of ciprofloxacin on the in-vitro activity of chloroquine against a clinical isolate of Plasmodium falciparum.
Topics: Animals; Antimalarials; Chloroquine; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Schizonts | 2006 |
Analytical interferences of drugs in the chemical examination of urinary protein.
Topics: Chloroquine; Ciprofloxacin; Clinical Laboratory Techniques; Humans; Pharmaceutical Preparations; Proteinuria; Quinine; Reagent Strips; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Effect of chloroquine on the bioavailability of ciprofloxacin in man.
Topics: Adult; Anti-Infective Agents; Antimalarials; Biological Availability; Chloroquine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male | 2006 |
Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei: interaction between ciprofloxacin and chloroqune.
Topics: Animals; Antimalarials; Chloroquine; Ciprofloxacin; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Survival Analysis; Treatment Outcome | 2012 |
Amodiaquine-Ciprofloxacin: a potential combination therapy against drug resistant malaria.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Plasmodium berghei | 2015 |
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.
Topics: Antiviral Agents; Binding Sites; Chloroquine; Ciprofloxacin; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Moxifloxacin; Nelfinavir; Protein Binding; SARS-CoV-2 | 2020 |